Canada Life’s Verastem VSTM Stock Holding History

Canada Life’s Portfolio VSTM Stock Details VSTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,614	Closed	-$23K	–	2652
2020 Q3	$23K	Hold	1,614	–	–	﹤0.01%	2417
2020 Q2	$33K	Buy	+1,614	New	+$42.7K	﹤0.01%	2374

Other funds holding VSTM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ACM

Altium Capital Management New York $47.5M AUM 115.72% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $143M AUM 773.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Canada Life's VSTM Position: Q4 2020 in Review

Canada Life sold out of Verastem (VSTM) in Q4 2020, closing a stake of 1,614 shares — an estimated $23K sold.

Canada Life first reported a position in VSTM in Q2 2020 and held it in 2 quarters. The position peaked at $33K in Q2 2020. 130 funds tracked by Wall St. Rank hold VSTM as of Q4 2020.

Canada Life reported no remaining Verastem position as of Q4 2020 after selling out during the quarter.
Canada Life sold 1,614 Verastem shares in Q4 2020, an estimated $23K.
Canada Life first reported a position in Verastem in Q2 2020 and held it in 2 quarters.
Canada Life's Verastem position peaked at $33K in Q2 2020.
130 funds tracked by Wall St. Rank held Verastem as of Q4 2020.

Based on Canada Life's 13F filing for Q4 2020, filed 16 Feb 2021.